rs1555761969
Variant summary
Our verdict is Pathogenic. The variant received 12 ACMG points: 12P and 0B. PVS1PM2PP5_Moderate
The NM_177559.3(CSNK2A1):c.783C>A(p.Tyr261*) variant causes a stop gained change. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★). Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_177559.3 stop_gained
Scores
Clinical Significance
Conservation
Publications
- Okur-Chung neurodevelopmental syndromeInheritance: AD Classification: DEFINITIVE, STRONG, MODERATE Submitted by: PanelApp Australia, Labcorp Genetics (formerly Invitae), Illumina, Ambry Genetics, G2P
- syndromic intellectual disabilityInheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 12 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_177559.3. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| CSNK2A1 | NM_177559.3 | MANE Select | c.783C>A | p.Tyr261* | stop_gained | Exon 11 of 14 | NP_808227.1 | ||
| CSNK2A1 | NM_001362770.2 | c.783C>A | p.Tyr261* | stop_gained | Exon 11 of 15 | NP_001349699.1 | |||
| CSNK2A1 | NM_001362771.2 | c.783C>A | p.Tyr261* | stop_gained | Exon 10 of 14 | NP_001349700.1 |
Ensembl Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| CSNK2A1 | ENST00000217244.9 | TSL:1 MANE Select | c.783C>A | p.Tyr261* | stop_gained | Exon 11 of 14 | ENSP00000217244.3 | ||
| CSNK2A1 | ENST00000400227.8 | TSL:1 | c.783C>A | p.Tyr261* | stop_gained | Exon 10 of 13 | ENSP00000383086.3 | ||
| CSNK2A1 | ENST00000349736.10 | TSL:1 | c.375C>A | p.Tyr125* | stop_gained | Exon 9 of 12 | ENSP00000339247.6 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Cov.: 30
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Inborn genetic diseases Pathogenic:1
The c.783C>A (p.Y261*) alteration, located in exon 11 (coding exon 9) of the CSNK2A1 gene, consists of a C to A substitution at nucleotide position 783. This changes the amino acid from a tyrosine (Y) to a stop codon at amino acid position 261. This alteration is expected to result in loss of function by premature protein truncation or nonsense-mediated mRNA decay. This variant was not reported in population-based cohorts in the Genome Aggregation Database (gnomAD). Based on the available evidence, this alteration is classified as pathogenic.
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at